Global Isocitrate Dehydrogenase Inhibitors Market Growth 2019-2024

July 2019 | 158 pages | ID: GA01091E691EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.

According to this study, over the next five years the Isocitrate Dehydrogenase Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Isocitrate Dehydrogenase Inhibitors business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Isocitrate Dehydrogenase Inhibitors market by product type, application, key manufacturers and key regions and countries.

This study considers the Isocitrate Dehydrogenase Inhibitors value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

• IDH1 Mutant Medullary Malignant Tumor
• IDH2 Mutant Medullary Malignant Tumor
• Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

• DH Inhibitor
• FLT3 Inhibitor
• Hedgehog Pathway Inhibitor
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• AGIOS
• Aslan Pharmaceuticals
• Bayer
• Beigene
• Bristol-Myers Squibb
• Celgene
• Daiichi Sankyo
• Philogen S.p.A.
• Tesaro
• Tragara/Adastra
• Tocagen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Isocitrate Dehydrogenase Inhibitors consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Isocitrate Dehydrogenase Inhibitors market by identifying its various subsegments.
• Focuses on the key global Isocitrate Dehydrogenase Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Isocitrate Dehydrogenase Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Isocitrate Dehydrogenase Inhibitors submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2019-2024 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Isocitrate Dehydrogenase Inhibitors Consumption 2014-2024
  2.1.2 Isocitrate Dehydrogenase Inhibitors Consumption CAGR by Region
2.2 Isocitrate Dehydrogenase Inhibitors Segment by Type
  2.2.1 IDH1 Mutant Medullary Malignant Tumor
  2.2.2 IDH2 Mutant Medullary Malignant Tumor
  2.2.3 Others
2.3 Isocitrate Dehydrogenase Inhibitors Consumption by Type
  2.3.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
  2.3.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Type (2014-2019)
  2.3.3 Global Isocitrate Dehydrogenase Inhibitors Sale Price by Type (2014-2019)
2.4 Isocitrate Dehydrogenase Inhibitors Segment by Application
  2.4.1 DH Inhibitor
  2.4.2 FLT3 Inhibitor
  2.4.3 Hedgehog Pathway Inhibitor
  2.4.4 Others
2.5 Isocitrate Dehydrogenase Inhibitors Consumption by Application
  2.5.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
  2.5.2 Global Isocitrate Dehydrogenase Inhibitors Value and Market Share by Application (2014-2019)
  2.5.3 Global Isocitrate Dehydrogenase Inhibitors Sale Price by Application (2014-2019)

3 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS BY MANUFACTURERS

3.1 Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturers
  3.1.1 Global Isocitrate Dehydrogenase Inhibitors Sales by Manufacturers (2017-2019)
  3.1.2 Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturers (2017-2019)
3.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturers
  3.2.1 Global Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturers (2017-2019)
  3.2.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Isocitrate Dehydrogenase Inhibitors Sale Price by Manufacturers
3.4 Global Isocitrate Dehydrogenase Inhibitors Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  3.4.1 Global Isocitrate Dehydrogenase Inhibitors Manufacturing Base Distribution and Sales Area by Manufacturers
  3.4.2 Players Isocitrate Dehydrogenase Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ISOCITRATE DEHYDROGENASE INHIBITORS BY REGIONS

4.1 Isocitrate Dehydrogenase Inhibitors by Regions
  4.1.1 Global Isocitrate Dehydrogenase Inhibitors Consumption by Regions
  4.1.2 Global Isocitrate Dehydrogenase Inhibitors Value by Regions
4.2 Americas Isocitrate Dehydrogenase Inhibitors Consumption Growth
4.3 APAC Isocitrate Dehydrogenase Inhibitors Consumption Growth
4.4 Europe Isocitrate Dehydrogenase Inhibitors Consumption Growth
4.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Growth

5 AMERICAS

5.1 Americas Isocitrate Dehydrogenase Inhibitors Consumption by Countries
  5.1.1 Americas Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019)
  5.1.2 Americas Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019)
5.2 Americas Isocitrate Dehydrogenase Inhibitors Consumption by Type
5.3 Americas Isocitrate Dehydrogenase Inhibitors Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Isocitrate Dehydrogenase Inhibitors Consumption by Countries
  6.1.1 APAC Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019)
  6.1.2 APAC Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019)
6.2 APAC Isocitrate Dehydrogenase Inhibitors Consumption by Type
6.3 APAC Isocitrate Dehydrogenase Inhibitors Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Isocitrate Dehydrogenase Inhibitors by Countries
  7.1.1 Europe Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019)
  7.1.2 Europe Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Consumption by Type
7.3 Europe Isocitrate Dehydrogenase Inhibitors Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors by Countries
  8.1.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019)
  8.1.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019)
8.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Type
8.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Isocitrate Dehydrogenase Inhibitors Distributors
10.3 Isocitrate Dehydrogenase Inhibitors Customer

11 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS MARKET FORECAST

11.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2019-2024)
11.2 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions
  11.2.1 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions (2019-2024)
  11.2.2 Global Isocitrate Dehydrogenase Inhibitors Value Forecast by Regions (2019-2024)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Isocitrate Dehydrogenase Inhibitors Forecast by Type
11.8 Global Isocitrate Dehydrogenase Inhibitors Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AGIOS
  12.1.1 Company Details
  12.1.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.1.4 Main Business Overview
  12.1.5 AGIOS News
12.2 Aslan Pharmaceuticals
  12.2.1 Company Details
  12.2.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.2.4 Main Business Overview
  12.2.5 Aslan Pharmaceuticals News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 Beigene
  12.4.1 Company Details
  12.4.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.4.4 Main Business Overview
  12.4.5 Beigene News
12.5 Bristol-Myers Squibb
  12.5.1 Company Details
  12.5.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.5.4 Main Business Overview
  12.5.5 Bristol-Myers Squibb News
12.6 Celgene
  12.6.1 Company Details
  12.6.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.6.4 Main Business Overview
  12.6.5 Celgene News
12.7 Daiichi Sankyo
  12.7.1 Company Details
  12.7.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.7.4 Main Business Overview
  12.7.5 Daiichi Sankyo News
12.8 Philogen S.p.A.
  12.8.1 Company Details
  12.8.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.8.4 Main Business Overview
  12.8.5 Philogen S.p.A. News
12.9 Tesaro
  12.9.1 Company Details
  12.9.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.9.4 Main Business Overview
  12.9.5 Tesaro News
12.10 Tragara/Adastra
  12.10.1 Company Details
  12.10.2 Isocitrate Dehydrogenase Inhibitors Product Offered
  12.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
  12.10.4 Main Business Overview
  12.10.5 Tragara/Adastra News
12.11 Tocagen

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Isocitrate Dehydrogenase Inhibitors
Table Product Specifications of Isocitrate Dehydrogenase Inhibitors
Figure Isocitrate Dehydrogenase Inhibitors Report Years Considered
Figure Market Research Methodology
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Growth Rate 2014-2024 (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Value Growth Rate 2014-2024 ($ Millions)
Table Isocitrate Dehydrogenase Inhibitors Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of IDH1 Mutant Medullary Malignant Tumor
Table Major Players of IDH1 Mutant Medullary Malignant Tumor
Figure Product Picture of IDH2 Mutant Medullary Malignant Tumor
Table Major Players of IDH2 Mutant Medullary Malignant Tumor
Figure Product Picture of Others
Table Major Players of Others
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type I
Table Major Players of Type I
Table Global Consumption Sales by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Type (2014-2019) ($ million)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sale Price by Type (2014-2019)
Figure Isocitrate Dehydrogenase Inhibitors Consumed in DH Inhibitor
Figure Global Isocitrate Dehydrogenase Inhibitors Market: DH Inhibitor (2014-2019) (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Market: DH Inhibitor (2014-2019) ($ Millions)
Figure Isocitrate Dehydrogenase Inhibitors Consumed in FLT3 Inhibitor
Figure Global Isocitrate Dehydrogenase Inhibitors Market: FLT3 Inhibitor (2014-2019) (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Market: FLT3 Inhibitor (2014-2019) ($ Millions)
Figure Isocitrate Dehydrogenase Inhibitors Consumed in Hedgehog Pathway Inhibitor
Figure Global Isocitrate Dehydrogenase Inhibitors Market: Hedgehog Pathway Inhibitor (2014-2019) (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Market: Hedgehog Pathway Inhibitor (2014-2019) ($ Millions)
Figure Isocitrate Dehydrogenase Inhibitors Consumed in Others
Figure Global Isocitrate Dehydrogenase Inhibitors Market: Others (2014-2019) (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Market: Others (2014-2019) ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Value by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Application (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sale Price by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Manufacturers (2017-2019) (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturers (2017-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturers in 2017
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturers in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturers (2017-2019) ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturers (2017-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturers in 2017
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturers in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Sale Price by Manufacturers (2017-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Sale Price by Manufacturers in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Manufacturing Base Distribution and Sales Area by Manufacturers
Table Players Isocitrate Dehydrogenase Inhibitors Products Offered
Table Isocitrate Dehydrogenase Inhibitors Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption by Regions 2014-2019 (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Regions 2014-2019
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Regions 2014-2019
Table Global Isocitrate Dehydrogenase Inhibitors Value by Regions 2014-2019 ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Regions 2014-2019
Figure Global Isocitrate Dehydrogenase Inhibitors Value Market Share by Regions 2014-2019
Figure Americas Isocitrate Dehydrogenase Inhibitors Consumption 2014-2019 (Kg)
Figure Americas Isocitrate Dehydrogenase Inhibitors Value 2014-2019 ($ Millions)
Figure APAC Isocitrate Dehydrogenase Inhibitors Consumption 2014-2019 (Kg)
Figure APAC Isocitrate Dehydrogenase Inhibitors Value 2014-2019 ($ Millions)
Figure Europe Isocitrate Dehydrogenase Inhibitors Consumption 2014-2019 (Kg)
Figure Europe Isocitrate Dehydrogenase Inhibitors Value 2014-2019 ($ Millions)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption 2014-2019 (Kg)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value 2014-2019 ($ Millions)
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019) (Kg)
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries (2014-2019)
Figure Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries in 2018
Table Americas Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019) ($ Millions)
Table Americas Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries (2014-2019)
Figure Americas Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries in 2018
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption by Type (2014-2019) (Kg)
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Figure Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type in 2018
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption by Application (2014-2019) (Kg)
Table Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Figure Americas Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application in 2018
Figure United States Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure United States Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Canada Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Canada Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019) (Kg)
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries (2014-2019)
Figure APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries in 2018
Table APAC Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019) ($ Millions)
Table APAC Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries (2014-2019)
Figure APAC Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries in 2018
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption by Type (2014-2019) (Kg)
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Figure APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type in 2018
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption by Application (2014-2019) (Kg)
Table APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Figure APAC Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application in 2018
Figure China Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure China Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Japan Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Japan Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Korea Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Korea Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure India Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure India Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Australia Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Australia Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019) (Kg)
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries in 2018
Table Europe Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019) ($ Millions)
Table Europe Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries in 2018
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption by Type (2014-2019) (Kg)
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type in 2018
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption by Application (2014-2019) (Kg)
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application in 2018
Figure Germany Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Germany Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure France Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure France Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure UK Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure UK Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Italy Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Italy Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Russia Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Russia Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Spain Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Spain Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Countries (2014-2019) (Kg)
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Countries in 2018
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value Market Share by Countries in 2018
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Type (2014-2019) (Kg)
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Type in 2018
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption by Application (2014-2019) (Kg)
Table Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application in 2018
Figure Egypt Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Israel Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Israel Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure Turkey Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure Turkey Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Isocitrate Dehydrogenase Inhibitors Consumption Growth 2014-2019 (Kg)
Figure GCC Countries Isocitrate Dehydrogenase Inhibitors Value Growth 2014-2019 ($ Millions)
Table Isocitrate Dehydrogenase Inhibitors Distributors List
Table Isocitrate Dehydrogenase Inhibitors Customer List
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Growth Rate Forecast (2019-2024) (Kg)
Figure Global Isocitrate Dehydrogenase Inhibitors Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast by Countries (2019-2024) (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Forecast by Regions
Table Global Isocitrate Dehydrogenase Inhibitors Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share Forecast by Regions
Figure Americas Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Americas Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure APAC Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure APAC Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Europe Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Europe Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure United States Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure United States Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Canada Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Canada Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Brazil Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Brazil Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure China Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure China Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Japan Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Japan Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Korea Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Korea Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure India Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure India Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Australia Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Australia Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Germany Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Germany Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure France Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure France Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure UK Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure UK Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Italy Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Italy Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Russia Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Russia Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Spain Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Spain Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Israel Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Israel Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure Turkey Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure Turkey Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Figure GCC Countries Isocitrate Dehydrogenase Inhibitors Consumption 2019-2024 (Kg)
Figure GCC Countries Isocitrate Dehydrogenase Inhibitors Value 2019-2024 ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast by Type (2019-2024) (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share Forecast by Type (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Value Forecast by Type (2019-2024) ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share Forecast by Type (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast by Application (2019-2024) (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share Forecast by Application (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Value Forecast by Application (2019-2024) ($ Millions)
Table Global Isocitrate Dehydrogenase Inhibitors Value Market Share Forecast by Application (2019-2024)
Table AGIOS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure AGIOS Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Aslan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Beigene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beigene Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Beigene Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Celgene Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Philogen S.p.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Tesaro Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Tesaro Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Tragara/Adastra Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Market Share (2017-2019)
Table Tocagen Basic Information, Manufacturing Base, Sales Area and Its Competitors